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To define the outcome of patients given medical or surgical
therapy for Q wave myocardial infarction, 387 patients
were followed up for 10 to 13 years (mean 11 .4) . On study
entry the groups had similar distributions for variables
such as mean age, gender, previous myocardial infarction,
abnormal creatine kinase activity, area of infarction, num-
ber of vessels diseased and clinical classification . The hos-
pital mortality rate of the medical versus surgical group
was 11 .5% (23 of 200) versus 5 .8% (11 of 187) (p = 0.07) .
Early reperfusion (that is,  56 h) resulted in a lower
mortality rate than did medical therapy-2% (2 of 100)
versus 11 .5% (23 of 200) (p < 0.05)-whereas the hospital
mortality rate with late reperfusion was 10 .3% (  of 87) .
The long-term mortality rate of the medical and surgical
groups was 41% (82 of 200) versus 27% (51 of 187) (p =
0.0007) with use of an adjusted Cox proportional hazards
model .
In the survivors, the differences between medical and
surgical groups in recurrent myocardial infarction, mortal-
ity associated with reinfarction and sudden death were
prospectively followed and evaluated by the life table
method. Recurrent myocardial infarction was not pre-
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vented by surgical reperfusion or medical therapy (23% in
both groups), however, the mortality rate in patients with
recurrent infarction was higher in the medical therapy
group-36 .6% (15 of 41) versus 17 .5% (7 of 40) (p = 0 .04) .
The mortality difference did not depend on early or late
surgical reperfusion . In the in-hospital survivors, the inci-
dence of sudden death was 17 .5% in the medical (31 of 177)
versus 7.4% (13 of 176) in the surgical group (p = 0 .01) .
This difference was much more pronounced in the early
reperfusion group . Functional class was significantly lower
than that for medical therapy in the early reperfusion but
not the late reperfusion group .
Thus, in comparable groups given medical and surgio .1
therapy for acute myocardial infarction and followed up for
>_10 years, surgical reperfusion appears to offer improved
longevity in selected cases (when implemented early) but
does not prevent recurrent myocardial infarction. The
associated mortality with recurrent myocardial infarction is
less as is the incidence of sudden death . Finally, lower
functional class occurs most often in patients given early
reperfusion.
(J Am Coil Cardiol 1 8 ;14 65-77)
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The extent of acute myocardial infarction develops over a
period of time (1- ) . Because the amount of acute and
chronic myocardial damage is correlated with short- and
long-term mortality (3-5), limitation of the extent of infarc-
tion has been aggressively pursued . Recent work has fo-
cused on restoration of coronary blood flow by thrombolytic
therapy (10-12), percutaneous transluminal coronary angio-
plasty (13), or both (13,14) . Before the advent of the newer
methods of reperfusion, initial attempts affecting restoration
0735- 1 7/8 /$3 .50
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of blood flow during early Q wave myocardial infarction
involved surgical reperfusion .
Early studies (15-18) as well as our own (1 -22) have
shown low hospital mortality with early surgical revascular-
ization . Despite low early mortality, it is unclear whether
surgical reperfusion would offer long-term advantages com-
pared with medical treatment in concurrently managed med-
ical and surgical groups with myocardial infarction and
similar baseline clinical variables . Although groups employ-
ing all vehicles of reperfusion have published data on early
hospital mortality and intermediate survival, little is known
regarding survival ? 10 years after medical or surgical treat-
ment of patients with acute Q wave myocardial infarction .
Whereas the primary goal of reperfusion is to interrupt
early myocardial damage after coronary occlusion, recent
trials (23,24) have also focused on protection from future
coronary-related events such as recurrent myocardial infarc-
tion and sudden death . Conceptually, surgical treatment
offers protection from postinfarction coronary-related
events because of the ability to bypass the infarct-related
vessel and other stenosed vessels . This protection may
obviate future clinical problems of restenosis and reocclu-
sion noted in some reports on thrombolytic reperfusion (25)
or coronary angioplasty (26) .
The goal of the present study is to compare findings after
10 years of follow-up study in patients treated with surgical
reperfusion or conventional therapy . Because future coro-
nary-related events have an adverse impact on survival in
the patient after infarction, we also investigated whether
surgical reperfusion altered the incidence of morbid events
such as recurrent myocardial infarction, associated mortality
due to recurrent infarction and the incidence of sudden
cardiac death between the conventionally or surgically man-
aged groups. Finally, we determined functional class in the
two groups on long-term follow-up .
Methods
Study patients . As reported in 1 7  (20), 415 patients
(aged 40 to 65 years) were admitted to the Sacred Heart and
Deaconess Medical Centers with a diagnosis of early acute Q
wave myocardial infarction between mid 1 72 and the end of
1 76. Early Q wave infarction was defined by chest pain, ST
segment elevation that evolved to abnormal Q waves and
abnormal evolution of total creatine kinase (CK) activity . Of
the 415 patients, 28 were considered ineligible for the study .
These included 8 patients with diffuse distal coronary dis-
ease, 7 with trivial coronary disease and II who were
considered too ill to survive either medical or surgical
therapy. An additional two patients were withdrawn retro-
spectively because they had leukemia on study entry . Of the
remaining 387 patients, all were admitted within 24 h of
symptom onset and all demonstrated acute current of injury
on the electrocardiogram (ECG) with chest pain, which
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qualified them for entrance into the study . Typical abnormal
Q waves evolved in all as did abnormal elevation of total CK
activity. Of the 387 patients, 200 received conventional
medical therapy and 187 underwent emergency surgical
coronary reperfusion .
These 415 patients accounted for all patients 40 to 65
years of age hospitalized within 24 h of symptom onset .
There were no other patients . The 28 patients withdrawn
retrospectively were believed to be either too sick (n = 21)
or at unusually low risk (n = 7) and may have imposed a bias
against medical or surgical therapy .
Patient selection . During the period under study, there
were four groups of cardiologists who supplied attending
cardiologists on a rotating schedule. In each group, one
cardiologist was on call for I entire day during the week .
Weekend call was divided equally as well . The practice
among groups comprised a spectrum. One group was very
supportive of acute surgical reperfusion whereas the other
groups favored conservative therapy . Medical management
was employed because the physician managing the case
treated acute myocardial infarction conventionally (n =
147) . Patients who did not present early in the time course
(n = 40), received conventional therapy . The onset of
symptoms was unclear in 10 patients, and 3 patients refused
to participate even though the cardiologist preferred acute
intervention . The number of patients in the present study
referred to each cardiologist was equal . Likewise, the vari-
ous groups were equally represented in their contribution of
patients to either medical or surgical therapy .
Logistics. When a patient presented to the emergency
room, usually the diagnosis was clear because of the clinical
findings, chest pain and ST segment elevation. Coronary
arteriography was available 24 h/day and the patient was
promptly referred to surgery after left heart catheterization .
Subsequently, the patient was immediately taken to the
operating room and coronary artery bypass surgery was
performed with use of the saphenous vein bypass method .
Ischemic arrest, cold blood and cold potassium cardioplegia
were used equally from 1 72 to 1 76 .
Electrocardiographic interpretation . The area of infarc-
tion was determined by the initial 12 lead ECG . Early
myocardial injury was defined as ST segment elevation .
Anterior wall infarction, defined when two or more precor-
dial leads were involved, included anterolateral, anterosep-
tal and lateral infarction . Inferior wall Q wave infarction
included inferior, inferoposterior, posterior and inferolateral
infarction . The percentage of early anterior and inferior Q
wave myocardial infarction in each group is listed in Table 1 .
To ensure uniformity, all ECGs were reviewed by one of the
principal investigators .
Clinical descriptors of patient groups (Table 1) . The con-
ventional therapy and surgical reperfusion groups were
compared in multiple clinical characteristics including age,
gender, previous myocardial infarction, biochemical evi-
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Table 1 . Clinical Characteristics of the Medical and Surgical Treatment Groups on Study Entry
dence of infarction on study entry, area of infarction, the
number of vessels diseased and the clinical classification on
hospitalization . The clinical classification was defined by the
method of Killip and Kimball (27). Significant coronary
disease was defined as >_50% coronary stenosis . The number
of vessels diseased was determined by presurgical coronary
arteriography in the surgical reperfusion group . The "50%"
level differs from our previous publication (20) (which de-
fined "significant" as >70%) because the lower figure re-
flected changes in clinical practice that have evolved over
the years . Coronary anatomy was determined in 73% (146 of
200) of the conventional therapy group either by postinfarc-
tion arteriography or by autopsy studies obtained within I
year of the infarction . All clinical classifications and coro-
nary arteriographic findings were reevaluated by a single
investigator to ensure uniformity .
Patients treated surgically were categorized as early (that
is, within 6 h) or late (that is, >6 h) from symptom onset . The
designation of "early" defined as <6 h" is arbitrary and
the clinical significance is unknown in humans . Cardiopul-
monary bypass was selected as the first identifiable interven-
tion because of the attendant hypothermia, which may
protect ischemic myocardium by cooling the myocardium
and lowering oxygen demand (28,2 ) .
Methods of follow-up data collection . During the study,
the medical and surgical patients were enrolled and prospec-
tively followed up on an annual basis by questionnaire . If the
questionnaire was not returned, the patient or a relative was
contacted to determine the health status of the patient,
functional status or morbid events subsequent to the index
infarction . Thus, although the patients were not randomly
allocated to medical or surgical therapy, they were prospec-
tively followed up. Follow-up studies were completed in
DEWOOD ET AL .
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*p values comparing conventional therapy and the column to the left of the p values ; tcoronary anatomic data were available in 73% of patients in the
conventional therapy group . CAD = coronary artery disease ; Ml = myocardial infarction .
1 85 to 1 86 . The mean follow-up period was 11 .4 years
(range 10 to 13) . Telephone contact was established with the
patient or a relative . If there had been subsequent hospital-
izations, the patient's physician was contacted and the
details of the hospitalization were clarified . The patient's
hospital charts were also reviewed in follow-up to determine
whether recurrent myocardial infarction had occurred .
Other major discrete clinical outcomes of interest included
recurrent myocardial infarction, mortality associated with
recurrent infarction, sudden cardiac death and functional
class. Details of follow-up hemodynamic studies are in an
accompanying report (30) .
The number of patients who crossed over to surgical
therapy after myocardial infarction was also determined .
The "intention to treat" principle was used . For example,
even though some survivors of medical therapy underwent
elective coronary bypass later, they were analyzed as pa-
tients receiving medical therapy .
Definitions . Recurrent myocardial infarction was deter-
mined by review of the hospital chart. Confirmatory ECG
and enzymatic evidence of myocardial infarction was re-
quired .
Mortality due to recurrent myocardial infarction was also
an outcome of interest . Because of the strict definition of
"reinfarction," we could only be aware of deaths due to
reinfarction in the hospital setting . However, few patients
with suspected recurrent infarction failed to reach a medical
care facility . The clinical characteristics of patients with
recurrent infarction are listed in Table 2 .
Sudden death was defined as death after a witnessed
cardiac arrest within I h of cardiac symptoms . The diagnosis
was not extended to patients who were successfully treated
for severe rhythm disturbances later resulting in electro-
Conventional
Therapy
Surgical Reperfusion
Overall p Value*
<6 h
p Value* >6 h p Value*
No. of patients 200 187 100 87
Age (yr)
56 ± 7 55 ± 7
0 .306
55 ± 7
0 .33  55 ± 6 0 .4 8
Previous MI 31 (16%) 32 (17%) 0 .682
1 0 %) 0.512 13 (15%) 1 .00
Area of MI
Anterior 102 (51%) 101 (54%) 51 (51%J 50 (57%)
Inferior  8 (4 %) 86 (46%)
0 .611
4  (4 %)
1 .00
37 (42%)
0 .368
Vessels with CAD'
1 63 (43%) 66(35 17() 38 (38%) 28 132%)
2 52 (35%)
70 (37%)
0 .273
36 (36%) 0.616 34 (3 %) 0 .20 
3 or 3+ 31 (21%) 51 (27%) 26(26%) 25 (2 %)
Clinical class on study entry
1 122 (61%) III (5 %) 61 (61%) 50 1'57%)
II
60(30%)
55 (2 %) 31 (31%) 24 (28%)
0 .358
0 . 76
0
.06 
111 10 (5%) 7 0%) 40%) 3 (3%)
IV 7 (3%) 14 (7%) 4 (4%) 1001%)
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Table 2 . Clinical Characteristics of 81 Patients With Recurrent Myocardial Infarction
physiologic investigation . The determination of sudden
death was made by direct contact with a person who was
knowledgeable about the patient's death. The clinical char-
acteristics of the patients who died suddenly are listed in
Table 3 .
Functional class was assigned to each patient at the end
of the follow-up period . A slightly modified version of the
New York Heart Association classification was used be-
cause the categories are based on an accepted stratification
reflecting left ventricular function . Class I was defined as no
limitations (ordinary physical activity does not cause undue
fatigue, dyspnea or palpitations) ; class II as slight limitation
*p values comparing conventional therapy and the column to the left of the p values   'coronary anatomic data were available in
83% of the conventional
therapy group . Abbreviations as in Table I .
Table 3 . Clinical Characteristics of 44 Patients With Sudden Death During Follow-Up
of physical activity (patients are comfortable at rest but
maximal physical activity results in fatigue or dyspnea) ;
class III as marked limitation of physical activity (patients
are comfortable at rest but less than maximal activity will
lead to symptoms of dyspnea or fatigue) and ; class IV as
inability to carry out any physical activity without symptoms
of fatigue or discomfort (some symptoms of congestive heart
failure are present even at rest)
. The clinical characteristics
of the patients with functional class defined are listed in
Table 4
.
Statistical analysis . The comparison of groups was per-
formed by the two sample t test, chi-square test or Fisher's
JACC Vol . 14, No
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*p values comparing conventional therapy and the column to the left of the p values
; !coronary anatomic data were available in 74% of the conventional
therapy group. Abbreviations as in Table I .
Conventional
Therapy
Surgical Reperfusion
Overall p Value* _<6 h p Value* >6 h
p Value*
No. of patients
31 13 3 10
Age (yr) 56 ± 7 54 ± 6 0 .4 2 58 ± 7 0 .644
53 ± 6 0 .2 3
Previous MI
6(20%) 3 (23%)
1
.00 0(0%) 1 .00 3 (80%) 0 .662
Area of MI
Anterior
18 (58%) 5 (38%)
0 .325
1 (33%)
0.571
4(40%)
0.46 
Inferior 13 (42%) 8 (61%) 2 (67%)
6(60%)
Vessels with CADt
1  (3 %) 3 (23%) 2 (67%)
1 (10%)
2
1003%)
5 (38%) 0
.338 0(0%) 0.345 5 (50%) 0 .175
3 or 3+
4 (17%) 5 (38%) 1 (33%)
4(40%)
Clinical class on study entry
I
1 (61%) 6(46%) 2 (67%)
4(40%)
II 10 (32%) 4 (31%) 1 (33%)
3 (30%)
0 .160
0 . 02 0 .073
III
2(6%)
1 (8%)
0(0%) 1 (10%)
IV
0(0%) 2 (15%) 0(0%)
2 (20%)
Conventional
Therapy
Surgical Reperfusion
Overall p Value* s6 h p Value* >6 h p Value*
No. of patients 41 40
24
16
Age (yr)
54 ± 7 54 ± 7 0 . 51 54 ± 8 0 . 04 54 ± 7 0 . 65
Previous MI 5 (12%) 10 (26%) 0 .157 8 (33%) 0 .056 2 (13%) 1 .00
Area of MI
Anterior 17 (41%)
22 (55%) 11 (46%)
11 (6 %)
0 .26 
0 .7 8
0.082
Inferior
24(58%)
18 (45%) 13 (54%)
5 (31%)
Vessels with CAD ,
1
14(41%)
16 (40%) 12 (50%)
4 (25%)
2 11 (32%) 13 (33%) 0 .  3 8 (33%) 0.653 5 (31%) 0 .405
3 or 3+  (26%) 11 (28%) 4(17%) 7 (44%)
Clinical class on study entry
1 30 (73%) 25 (63%) 15 (63%)
10 (63%)
11 10(24%) 12 (30%) 8 (33%) 4 (25%)
0 .444 0.65  0 .301
111 1 (2%) 3 (8%) 1 (4%) 2 (13%)
IV
0(0) 0(0%) 0(0%) 0(0%)
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Table 4. Clinical Characteristics of 245 Patients With Functional Class Determination at Follow-Up
exact test as appropriate . Comparison for the time to an
event (that is, death, recurrent infarction or sudden death)
was presented for the life table method (31) to deal with
potential confounding . Adjustment for covariates was per-
formed with use of the Cox proportional hazards regression
model (31) . The covariate analysis proceeded in two stages .
First, prognostic covariates, excluding therapy, were se-
lected by stepwise, step-up Cox regression . The assigned
therapy was then added to the prognostic model to see
whether it gave some additional prognostic power. The
possible prognostic characteristics considered were the pa-
tient's gender, presence or absence of previous myocardial
infarction, location of the current myocardial infarction (that
is . anterior or inferior wall), Killip class on study entry and
number of vessels diseased . Table 5 presents the multivari-
ate analysis for the variables believed to have potential
prognostic importance . The sample size of each outcome
was different and depended on the number of patients with
known values for the variable .
Results
Follow- Up Measurements
Follow-up information was available in  8% (185 of 187)
of the surgical reperfusion group and in  3% (186 of 200) of
the conventional therapy group . Because both groups had an
equal chance of sustaining mortality or morbidity, both
cardiac and noncardiac deaths were included in the analysis .
Overall comparability of medical and surgical groups
(Table 1) . The overall groups were similar in average age,
incidence of previous infarction, area of infarction by ECG,
number of patients with multivessel disease (when known)
or clinical classification, although there were fewer patients
DEWOOD ET AL .
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*p values between conventional therapy and the column to the left of the p values   coronary anatomic data were available in 76%r of the conventional therapy
group . Abbreviations as in Table I .
with cardiogenic shock in the medical than in the surgical
group (7 of 200 versus 14 of 187, p = 0 .08) . The criteria for
cardiogenic shock are listed elsewhere (32) . The patients
receiving medical therapy were hospitalized 7 .6  ± 4.8 h
after symptom onset compared with 7 .67 ± 5 h in patients
receiving surgical therapy (p = NS) .
Comparability of early and late surgical reperfusion groups
(Table 1) . Of the 187 surgical patients, 100 were placed on
cardiopulmonary bypass within 6 h of symptom onset (mean
4.8 ± 0.1 h). In the remaining 87 patients- the time to
cardiopulmonary bypass after symptom onset averaged I 1 ±
6 h . There were no major baseline clinical differences
between the overall surgical group and the early and late
reperfusion groups except that more patients in clinical class
IV were in the late surgical reperfusion group . Therefore,
patients with late reperfusion may have been slightly more ill
on study entry than those with early reperfusion. Neverthe-
less, the frequency of clinical classes I . II and III was similar
in the two groups .
The coronary arteriographic findings did not reflect more
extensive coronary artery disease in the early versus the late
reperfusion group (Table 1) . This finding is important be-
cause all patients in both of these groups had undergone
arteriography and assessment of left ventricular function
before operation . In contrast 54 patients in the conventional
therapy group did not undergo arteriographic studies be-
cause 1) their clinical state was so poor that the attending
doctor believed that invasively derived information would
not change therapy ; 2) they died before performance of the
arteriogram ; or 3) permission for autopsy was not granted .
The frequency of one, two and three vessel disease was
known in 73% (146 of 200) of the conventional therapy group
either by postinfarction arteriography (n = 12 ) or by
Conventional
Therapy
Surgical Reperfusion
Overall p Value* -6 h p Value* >6 h
p Value*
No . of patients 117 128 74
54
Age (yr) 55 ± 7 55 ± 7 0 .861 55 ± 7 0 . 78 55
- 7 0.721
Previous Ml 11 ( 5O 25 (20%) 0 .030 16127) 0 .031   (17%)
0 .202
Area of MI
Anterior 51 (447) 68 (53 1/) 34 (46%r)
34 (6350
11 .160 0
.767 0 .02'
Inferior
66 (56/) 60 (467) 40 (54%) 20 (37( 
)
Vessels with CAD ,
1 37 (42%) 46 (367 )
27 (37r/) 1  (35l%)
2 28 (31%) 52 (40 1/r) 0 .388 2  (3 %) 0
.587 23 (43'/) 0 .403
3 or 3+ 24 (2714)
30 (237 ( 18 ( 2 4'3)
12 (22%)
Clinical class on study entry
I 83 (71%) 8  (707) 50 (W()
3  (72`4)
Il
30126%O 34 (27%) 21 ('_K/r( 13 (24(%)
0 . 60 0.681 0 .880
ill 3 (37r) 3 (20%)
I (1%)
2
(4%)
IV I (1(~/() 2 (2(lS) 2 (3/r) O (0
1
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Table 5 . Evaluation of Therapy Adjusting for Statistically Significant Prognostic Variables*
autopsy (n = 17) performed after hospital death or within I
year of the infarction .
Mortality
Medical versus surgical groups (Table 5). Mortality and
global and regional left ventricular data in the patients with
anterior and inferior infarction are shown in the accompa-
nying report (30) . Table 5 represents the p values for
therapeutic comparison with use of the Cox proportional
hazards adjustment as described under statistical methods .
As is clarified later, this test demonstrated an improved
JACC Vol . 14, No. I
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*Potential adjustment variables were age, gender, previous myocardial infarction (MI), location of infarction, Killip class and number of vessels diseased (see
text for details)   tnot in model .
survival associated with surgery for the entire group (p =
0.0007) and for those operated on within 6 h of the onset
of the infarction (p = 0 .0003) . The estimated relative
risks of medical versus surgical therapy and their  5%
confidence intervals for these two groups are 1 .88 (1 .55,
4 .36) and 2 .60 (1 .31, 2.71), respectively. A therapeutic
effect was not shown in the patients who underwent sur-
gery >6 h after symptom onset of the index infarction . The
effect of time from symptom onset to surgery was investi-
gated in the group of patients receiving surgery . In a step-up
Cox analysis, time to surgery was prognostic for death (p
0.0003) .
Patient Group End Point
Model Without Therapy Adding Therapy
Variable
Entered
Univariate
p Value
Multivariate
p Value
Multivariate
p Value
Instantaneous
Relative Risk
of Medicine
Versus Surgery
All patients Recurrent MI None
Therapy
N/A N/A
0 .62
Sudden death Killip class 0.037 0.037
0.0167
Therapy 0.0021 2 .78
Death Killip class <0.0001 <0.0001 <0.0001
MI location 0.0055 (0.0 72)t N/A
Vessels 0 .1416 0.022
0 .12
Gender 0 .3145 0.015 0 .27
Therapy 0 .0006  1 .88
Surgery s6 h from onset and
medical patients
Recurrent MI None
Therapy 0 .   -
Sudden death None
Therapy 0 .0005
6 .23
Death Killip class <0.0001 <0 .0001 <0 .0001
MI location 0 .0002 0 .020  0 .011
Vessels
0 .022  0
.003  0 .072
Gender 0 .1 02 0 .0135
0 .031
Prior MI 0.0726 0 .0337 0.020
Therapy
0 .00020 2 .60
Surgery >6 h from onset and
medical patients
Recurrent MI None
Therapy
N/A N/A
0.40
Sudden death Killip class 0 .0141 0 .0140
0.010
Therapy - - 0.185
Death Killip class <0 .000I
<0.0001 <0.0001
MI location 0 .0184 (0 .18 )t 0 .175
Vessels 0 .338 0 .03  0 .171
Therapy
0 .1 1
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Figure 1 . Survival for the medical and surgical
groups after acute myocardial infarction (MI) .
There is a trend toward differing in hospital mor-
tality rate (11 .5% versus 5 .8%, p = 0 .07) . The
vertical bars represent times of last follow-up (to
the nearest month) of patients alive at the last
follow-up . The curves are the Kaplan-Meier prod-
uct limit survival curves ; the p value is adjusted for
other prognostic variables (see text) by the Cox
proportional hazards model (the unadjusted log-
rank p value is 0 .0012) .
Short-term mortality rate (Fig . I and 2). The hospital
mortality rate was different in the conventional therapy and
surgical treatment groups (11 .5% [23 of 200] versus 5 .8% [11
of 1871, p = 0 .07) . Figure 2 demonstrates that the hospital
mortality rate of the early reperfusion group was also lower
than that of the conventional therapy group (2% [2 of 100]
versus 11 .5% [23 of 200], p < 0 .01) . Also, the early reperfu-
sion group demonstrated a lower hospital mortality rate than
did the late reperfusion group (2% [2 of 100] versus 10.3% [ 
of 87], p < 0 .05) . No difference in early mortality was
observed between the late reperfusion and conventional
therapy groups .
Long-term mortality rate (Fig . 1 and 2). The long-term
cumulative mortality rate widened between the conventional
and surgical groups (estimated 10 year survival 5 % conven-
tional versus 74% surgical, Cox p value = 0 .0007) . Also, as
Figure 2. Survival of the medical
	
0.8"
group versus the early surgical group
(<6 h from the onset of symptoms) and
late surgical group (>6 h from the
onset of symptoms). The in-hospital
mortality is higher in the medical group
(23/200, 11 .5%) and in the late surgery
group ( /87, 10 .3%) than that in the
early surgery group (2/100, 2%) (p <
0.01 and p < 0 .05, respectively) . Prod-
uct limit curves are given with p values
adjusted for prognostic covariates by
the Cox proportional hazards model .
Abbreviation as in Figure 1 .
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shown in Figure 2, the cumulative mortality rate of the early
reperfusion group was significantly lower than that of the
conventional therapy group (estimated 10 year survival 83%
versus 5 %, Cox p = 0 .0003), respectively . A lower mortal-
ity rate in the early versus the late reperfusion group
(estimated 10 year survival 83% versus 66%, Cox adjusted p
value = 0 .0233) was also observed . There was no significant
difference in long-term mortality between the late reperfu-
sion group and the conventionally managed group .
Recurrent Myocardial Infarction
Medical versus surgical group . Most clinical characteris-
tics of the medically and surgically treated patients who
sustained recurrent infarction were similar (Table 2). A
preponderance of patients in the surgical reperfusion group
CONVENTIONAL
ADJUSTED COX PROPORTIONAL HAZARDS
CONVENTIONAL VS . SURGERY <= 6 HOURS P = 0 .0003
CONVENTIONAL VS . SURGERY > 6 HOURS P a 0
.1 1
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Figure 3. Incidence of recurrent myocardial infarction and mortal-
ity due to recurrent myocardial infarction in the medical versus the
overall surgical group and the surgical subgroups . There was no
prevention of recurrent infarction, although mortality after recurrent
infarction was significantly less in the surgical group . The p values
are the Cox proportional hazards p values adjusted for covariates .
had anterior infarction on study entry. By contrast, the
conventional therapy group had more patients with inferior
infarction
. These differences were not statistically significant
and the basis of these findings is unknown
. Nevertheless,
when considering coronary arteriogranhic findings . the num-
ber of patients with one, two and three vessel disease was
similar as was the clinical classification on study entry . In
both groups, the majority of patients with recurrent infarc-
tion were in clinical class I or II on study entry .
A cornerstone finding in the present study is illustrated in
Figure 3 .
Coronary bypass surgery did not prevent recurrent
myocardial infarction over the long-term follow-up period .
There was an equal occurrence of recurrent myocardial
infarction in the conventionally managed and the surgical
reperfusion groups overall (estimated actuarial 10 year oc-
currence of recurrent infarction 74% of medically treated
versus 75% of surgically treated patients, Cox p = 0 .62) .
Among the surgical cases in the step-up Cox run, time to
surgery was not prognostic for a recurrent myocardial in-
farction (p = 0 .23) .
Location of recurrent myocardial infarction . In the con-
ventionally managed patients, recurrent myocardial infarc-
tion occurred in a similar location in 41% (17 of 41), whereas
a new area of involvement was observed in 5 % (24 of 41) . In
the surgical reperfusion group, of the 40 patients who
sustained a recurrent myocardial infarction, 38% (15 of 40) of
the infarcts were in the distribution of the original infarct and
occurred because of an occluded bypass graft . In the remain-
ing 63% (25 of 40), recurrence of infarction was secondary to
progression of coronary artery stenosis in previously unin-
volved vessels .
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Mortality associated with acute myocardial infarction
.
Figure 3 demonstrates that mortality associated with a new
myocardial infarction was significantly higher in the conven-
tional versus surgical therapy groups overall (36 .6% [15 of
41] versus 17.5% [7 of 40], p = 0.05)
. The mortality rate
associated with recurrent myocardial infarction was equally
distributed between the two surgical subgroups (that is, 17%
[4 of 24] in the early group and 18.7% [3 of 16] in the late
group) .
•
H
•
U
Sudden Death
Clinical characteristics of patients who had sudden cardiac
death during follow-up (Table 3) . The treatment groups were
similar in clinical characteristics on study entry . As with the
group that sustained recurrent myocardial infarction, there
was a preponderance of prior anterior infarction in the
conventional therapy group and more prior inferior infarc-
tion in the surgery group but the difference was not statisti-
cally significant
. The reasons for this trend are unknown
although others have observed that a major factor associated
with sudden death after myocardial infarction is the low
ejection fraction (33,34) that frequently occurs with anterior
infarction (33) .
Incidence of sudden death (Table 5). Sudden death oc-
curred less frequently in the surgical than in the medical
group among all patients (p = 0.0021); the relative risk was
higher for medicine versus surgery with a  5% confidence
level 2 .78 (1 .45, 5 .34) (Fig . 4) . This result also held when
patients treated surgically _56 h after the onset of myocardial
infarction were compared with medically treated patients (p
= 0.0005); relative risk = 6 .28 with a  5% confidence
interval (1 . 2, 20 .57). The medical therapy group had more
sudden death than did the surgical group (estimated 10 year
actuarial percent of patients with sudden death   medical 83%
versus surgical  3%, Cox p = 0 .0021) (Fig. 4) . This result
was especially so in the early surgical reperfusion group that
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Figure 4 . Incidence of sudden death (as defined in the text) . There
was significant reduction in the incidence of sudden death in the
surgical group . This reduction was especially prevalent in the early
reperfusion group, but not in the late reperfusion group
.
demonstrated lower sudden death (10 year actuarial percent
dying suddenly   83% medical versus  7% surgical, Cox p
value = 0 .0005) than the conventional therapy group . There
was no difference in the occurrence of sudden death between
the medical therapy group and the late surgical reperfusion
group (estimated 10 year percent dying suddenly   83% of
medical versus 88% of surgical, Cox p value = NS) .
Functional Classification on Long-Term
Follow-Up (Table 4)
Of the patients who survived the follow-up period,   %
(117 of 118) in the conventional therapy group and  5% (12 
Figure 5. Functional class in the medical
therapy group, the surgical therapy group
and the early and late surgical reperfusion
groups. The overall surgical group and the
early surgical group had significantly bet-
ter functional class than did the conven-
tional therapy or late surgical groups .
P-042
P-_03 
\\`
IV
of 136) in the surgical group could be assigned a functional
classification . There were no major differences in clinical
characteristics between the two groups on study entry .
Figure 5 demonstrates the frequency of functional class 1,
11, III and IV on long-term follow-up in the medical and
surgical groups . Overall, the total surgical group and the
subgroup with early surgical reperfusion (~6 h) had a lower
functional class than did the conventional therapy group .
The frequency of functional class I was highest and that of
class IV was lowest in the early surgery group .
Discussion
The long-term (? 10 years) outcome of patients sustaining
a Q wave myocardial infarction is unknown . Most reports
contain shorter-term data and focus on mortality (35-38) .
The present study was designed to investigate additional
markers that might reflect limitation of infarct size and the
possible effects on future coronary-related events .
Mortality . Short-term mortality . Although the medical
and surgical groups had similar clinical characteristics on
study entry, there was evidence for significant reduction in
mortality in the patients with surgical reperfusion . This was
especially noticeable in the early reperfusion group ; in
contrast, hospital mortality in the late reperfusion group was
significantly different from that of the medically treated
group. These differences may be partly explained by limita-
tion of infarct extension in the patients with early reperfu-
sion. Nevertheless, careful scrutiny of Table I indicates that
the patients with late reperfusion may have been a slightly
sicker group. Underscoring the importance of preoperative
cardiogenic shock is that it accounted for (73% [8 of 11 ]) of
hospital deaths in the surgically treated group .
It is unlikely that the difference in mortality was attribut-
able to a more compromised medical group . This is so
because cardiogenic shock was mostly removed from this
group specifically to avoid a bias . Furthermore, 18 of 23
P- .284
I II In
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hospital deaths in the medical group were not in patients in
functional class IV on study entry . Likewise, almost all
patients (387 of 415 [ 3%]) who were eligible for the study
were included . Of the 28 patients who were excluded, 7 had
coronary arteriograms performed before infarction that indi-
cated a small territory of risk and none died . In the remaining
21 patients who were "too ill," inclusion of these patients
would have biased the results against conventional therapy
because their mortality rate was 81% (17 of 21) . Importantly,
each cardiology group had different practice patterns and
there were variable referral patterns in the community .
Because of the variability of the referral patterns and the
differing behavior of the attending cardiologists there was
nearly equal allocation of each type of therapy . This result
also may account for the insignificant clinical differences of
the medical and surgical groups on study entry .
Appropriateness of the medical therapy group . The
present study might be impaired because it was nonrandom-
ized and uncontrolled . Accordingly, objections (3 ,40) may
include the issue of whether the medical group is an appro-
priate cohort for comparison with the surgical reperfusion
group. The adjustments made by the Cox proportional
hazards regression model help to minimize bias . The dif-
ferent therapeutic strategies of the attending cardiologists
suggest a nearly random allocation to therapy if one assumes
that the timing of a new myocardial infarction is random and
evenly distributed over time . Review of Table I indicates
that the groups were very similar. On clinical grounds, if
there was a bias, the medical therapy group should have
demonstrated greater mortality than that observed in pa-
tients from nonrandomized or randomized clinical trials .
Review of reported data (2 ,36,37,41) indicates that the
mortality of the present medical group was unusually low .
Similarly, review of randomized trials (10,25,42-46) indi-
cates that the medical patients in the present study had a
short-term mortality uniformly similar to that of medical
patients generated by random allocation . Thus, the medical
group appears to accurately reflect the biology of acute
myocardial infarction as it has been described in both
randomized and nonrandomized clinical trials .
An important question is whether the medical therapy
group is similar to the patients treated surgically . Table 1
indicates that there were no significant differences between
the two groups except for more cardiogenic shock in the
surgical group. Therefore, if bias was present it was against
the surgical therapy group as more Killip class IV patients
were included . These patients could not be excluded a
posteriori . Importantly, if patients with cardiogenic shock
had been removed from the surgical group, the in-hospital
mortality rate in this group would have been 1 .7% (3 of 173)
irrespective of early or late reperfusion . Nevertheless, the
group receiving late reperfusion continued to show progres-
sively higher cumulative long-term mortality (Fig . 2) .
Long-term mortality . Few randomized trials have fol-
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lowed up conventionally treated patients for >3 years .
Accordingly, there is a scarcity of information on the long-
term mortality after Q wave infarction . Six year mortality
figures have been described by Pedersen (47) after myocar-
dial infarction ; their data indicate mortality rates similar to
those of the medically managed group in our study . Obser-
vational studies (38,48-56) suggest that the long-term mor-
tality and the clinical characteristics of our conventional
therapy group are similar to those of virtually every recent
medical therapy group . Nevertheless, the surgical group had
significant improvement in long-term survival (Fig . 1 and 2) .
That was evident in those with early but not late surgery .
Recurrent myocardial infarction . The Framingham study
(38) demonstrated a 26% rate of infarction after 10 years of
follow-up study ; others (50) have observed an even higher
rate . Randomized clinical trials (23) indicate that the reinfarc-
tion rate is 20% at a mean follow-up interval of 33 months .
Thus, the studies are in agreement with the incidence of
recurrent infarction in our conventional therapy group (Fig .
3). Unfortunately, recurrent myocardial infarction was not
prevented by surgical therapy .
Mortality due to reinfarction . Although there was no
differences in the rate of recurrent myocardial infarction
between the medical and surgical groups, the surgically
treated patients had a significant reduction in mortality as
result of reinfarction (Fig . 3) . This protective effect was
observed in both the early and the late reperfusion group
although it was not statistically significant in these smaller
subgroups. A potential explanation is that the surgically
treated patients had been protected from mortality associ-
ated with recurrent ischemic events because bypass grafting
of vessels uninvolved with the previous infarct had been
performed . An equally plausible explanation is that the
initial infarct was limited, the patients had maintained better
left ventricular function and were better able to withstand a
new infarct . Observational studies (57) have demonstrated
differing mortality due to recurrent myocardial infarction
depending on whether the infarct was Q wave or non-Q
wave. One randomized trial (47) indicated that the cumula-
tive mortality rate associated with reinfarction was ?40% in
both placebo and treatment groups followed-up for >6
years. Our study indicates that bypass grafting for acute
myocardial infarction may reduce subsequent mortality
should reinfarction occur . The importance of the initial
infarct relative to the recurrent infarct has not been suffi-
ciently investigated . One might expect recurrent infarction
after prior anterior infarction to be associated with a higher
mortality. This result was observed in the conventional
therapy group but not in either reperfusion subgroup .
Incidence of sudden death . Whether bypass surgery pre-
vents sudden cardiac death is uncertain . Vismara et al . (58)
indicated that there was a threefold higher incidence of
sudden death in patients with chronic stable angina who
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received medical rather than surgical therapy . Few data are
available on survivors of acute myocardial infarction .
The significant reduction of sudden death in the surgically
treated patients occurred only in the early reperfusion sub-
group (Fig. 4). In contrast, the incidence of sudden cardiac
death in the medical group was similar to that of a recently
reported controlled randomized trial (23) and observational
studies (5 ,60) . The mechanism responsible for the reduction
in sudden death in the early reperfusion group is unclear but
this finding may in part reflect complete revascularization
and less ventricular dysfunction after the index infarct (see
DeWood [30]) .
Functional class . To evaluate the results of medical and
surgical therapy, functional class was assigned to the pa-
tients who had survived ? 10 years . These data are unique in
that functional class has not been defined in a long-term
postinfarction population . One randomized clinical trial (61)
evaluated functional class at 6 months of follow-up and
found no difference in functional classification between
patients treated with intracoronary streptokinase or conven-
tional medical therapy . The patients with early surgical
reperfusion were more likely to have less functional impair-
ment at follow-up study (Fig . 5). Whether this outcome
reflects better exercise performance due to increased left
ventricular reserve in this group was not formally studied .
Criticisms of surgical reperfusion . The randomized con-
trolled clinical trial is the definitive tool for evaluating the
effectiveness of a therapy. For local reasons (62), we have
been unable to perform such a study . Although mathematical
adjustments support the efficacy of surgical reperfusion
(Table 5), doubts will remain . Our previous data (20,21) and
other work (63) have received extensive criticism (3 ,40,64) .
It is noteworthy, however, that some investigators (3 ) have
subsequently confirmed our statistics on mortality with
medical (43) and surgical (65) treatment of acute myocardial
infarction .
Within the first few hours of infarction, can the outcome
at ?10 years be predicted? As is indicated in this study and
in data from a recent large randomized clinical trial (10),
most patients are at low risk when seen in the early hours of
acute myocardial infarction ; as the infarct evolves, expands
or extends, their clinical state becomes unstable . At this
point in the evolution of infarction, it is unknown whether
myocardial salvage is possible . Our approach has been an
attempt to keep patients in functional classes I and 11 in a low
risk category and thereby avoid cardiogenic shock . This fact
is important because patients in clinical class I and II
constituted the majority of the present study . Alternatively,
the functional state of the medically treated patients deteri-
orated to class IV, which was the major cause of death .
The major shortcoming of this clinical trial (apart from its
nonrandomized protocol) is that the medical therapy group
did not uniformly have baseline left ventriculography and
coronary arteriography . It is unlikely that the coronary
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arteriographic findings differed in the medical and surgical
groups, since all patients demonstrated persistent ST seg-
ment elevation on the ECG in conjunction with chest pain
and cardiac enzyme abnormalities (66) . Thus, the early
pathophysiology associated with acute myocardial infarction
should be similar in the two groups . This argument is further
buttressed by comparing the clinical behavior of the medical
therapy group with that of other published series (10,17,36-
3 ,41-56) in terms of mortality, reinfarction, associated
mortality with recurrent infarction and the incidence of
sudden cardiac death after infarction .
Conclusions . Despite the limitations of our study, the
data indicate that in patients given medical or surgical
therapy for acute Q wave myocardial infarction and followed
up for >_ 10 years, early surgical reperfusion appears to offer
improved longevity. Although surgical therapy fails to pre-
vent recurrent infarction, it appears to reduce the mortality
associated with reinfarction. Similar encouraging results
were observed in a reduction of sudden cardiac death and
improved functional class in patients receiving early surgical
reperfusion .
We acknowledge the contributions of Cynthia Brandt for typing the manu-
script and supplying organizational support and Gary Schoch for computer
science support .
Addendum
Since submission of this study, a randomized trial com-
paring medical and surgical therapy of M .I . has been pub-
lished . It confirms the mortality results in the present study .
Koshal A, Beanlands DS, Davies RA, Nair RC, Keon WJ .
Circulation 1 88 ;78(supp 1)  171-7 .
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